254 related articles for article (PubMed ID: 9115968)
21. 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.
Avet-Loiseau H; Garand R; Lodé L; Robillard N; Bataille R
Semin Oncol; 2003 Apr; 30(2):153-5. PubMed ID: 12720126
[TBL] [Abstract][Full Text] [Related]
22. Chromosomes in plasma-cell malignancies.
Van Den Berghe H
Eur J Haematol Suppl; 1989; 51():47-51. PubMed ID: 2697595
[TBL] [Abstract][Full Text] [Related]
23. Identification of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined G-banding, spectral karyotyping, and fluorescence in situ hybridization analyses.
Sáez B; Martín-Subero JI; Largo C; Martín MC; Odero MD; Prosper F; Siebert R; Calasanz MJ; Cigudosa JC
Cancer Genet Cytogenet; 2006 Sep; 169(2):143-9. PubMed ID: 16938572
[TBL] [Abstract][Full Text] [Related]
24. In vitro maintenance and retroviral transduction of human myeloma cells in long-term marrow cultures.
Stewart AK; Prince HM; Cappe D; Chu P; Lutzko C; Sutherland DR; Dubé ID
Cancer Gene Ther; 1997; 4(3):148-56. PubMed ID: 9171933
[TBL] [Abstract][Full Text] [Related]
25. Frequent gains of the short arm of chromosome 9 in multiple myeloma with normal G-banded karyotype detected by comparative genomic hybridization.
Tchinda J; Volpert S; Kropff M; Berdel WE; Kienast J; Meinhardt F; Horst J
Am J Clin Pathol; 2004 Dec; 122(6):875-82. PubMed ID: 15539380
[TBL] [Abstract][Full Text] [Related]
26. [Cytogenetic characteristics of patients with multiple myeloma in China: analysis of 100 case].
Deng SH; Xu Y; Wang YF; Mai YJ; Liu XP; Zhao YZ; Zou DH; Wang Y; Qiu LG
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1685-8. PubMed ID: 17825148
[TBL] [Abstract][Full Text] [Related]
27. CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q.
Liebisch P; Eppinger S; Schöpflin C; Stehle G; Munzert G; Döhner H; Schmid M
Haematologica; 2005 Apr; 90(4):489-93. PubMed ID: 15820944
[TBL] [Abstract][Full Text] [Related]
28. Cytogenetic data as a prognostic factor in multiple myeloma patients: involvement of 1p12 region an adverse prognostic factor.
Panani AD; Ferti AD; Papaxoinis C; Raptis SA; Roussos Ch
Anticancer Res; 2004; 24(6):4141-6. PubMed ID: 15736465
[TBL] [Abstract][Full Text] [Related]
29. [Cytogenetic studies of some hemopathies].
Vulpis G
Omnia Med Ther; 1967; 45(1):1-33. PubMed ID: 4971275
[No Abstract] [Full Text] [Related]
30. Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin's disease.
Falzetti D; Crescenzi B; Matteuci C; Falini B; Martelli MF; Van Den Berghe H; Mecucci C
Haematologica; 1999 Apr; 84(4):298-305. PubMed ID: 10190942
[TBL] [Abstract][Full Text] [Related]
31. Karyotype in multiple myeloma and plasma cell leukaemia.
Weh HJ; Gutensohn K; Selbach J; Kruse R; Wacker-Backhaus G; Seeger D; Fiedler W; Fett W; Hossfeld DK
Eur J Cancer; 1993; 29A(9):1269-73. PubMed ID: 8343266
[TBL] [Abstract][Full Text] [Related]
32. Chromosomal aberrations of multiple myeloma in Chinese patients at diagnosis: a study by combined G-banding and multicolor spectral karyotyping.
Ng MH; Wong N; Lau TT; Tsang KS; Cheng SH; Chan NP; Tang SH; Lei KI; Leung Y
Oncol Rep; 2003; 10(3):587-91. PubMed ID: 12684628
[TBL] [Abstract][Full Text] [Related]
33. Analysis of G banded karyotypes in myeloma cells.
Chen KC; Bevan PC; Matthews JG
J Clin Pathol; 1986 Mar; 39(3):260-6. PubMed ID: 3457025
[TBL] [Abstract][Full Text] [Related]
34. [Chromosome findings in multiple myeloma].
Suzuki K
Nihon Rinsho; 1995 Mar; 53(3):568-73. PubMed ID: 7699887
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetic findings in mouse multiple myeloma and Waldenström's macroglobulinemia.
van den Akker TW; Radl J; Franken-Postma E; Hagemeijer A
Cancer Genet Cytogenet; 1996 Feb; 86(2):156-61. PubMed ID: 8603345
[TBL] [Abstract][Full Text] [Related]
36. High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparation.
Nilsson T; Lenhoff S; Rylander L; Höglund M; Turesson I; Mitelman F; Westin J; Johansson B
Br J Haematol; 2004 Aug; 126(4):487-94. PubMed ID: 15287940
[TBL] [Abstract][Full Text] [Related]
37. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
[TBL] [Abstract][Full Text] [Related]
38. Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course.
Mansoor A; Medeiros LJ; Weber DM; Alexanian R; Hayes K; Jones D; Lai R; Glassman A; Bueso-Ramos CE
Am J Clin Pathol; 2001 Oct; 116(4):543-9. PubMed ID: 11601139
[TBL] [Abstract][Full Text] [Related]
39. Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
Wu KL; Beverloo B; Lokhorst HM; Segeren CM; van der Holt B; Steijaert MM; Westveer PH; Poddighe PJ; Verhoef GE; Sonneveld P; ;
Br J Haematol; 2007 Feb; 136(4):615-23. PubMed ID: 17223915
[TBL] [Abstract][Full Text] [Related]
40. Differences in bone marrow cytogenetic characteristics between treated and untreated myeloma.
Clark RE; Geddes AD; Whittaker JA; Jacobs A
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1789-93. PubMed ID: 2632260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]